Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman, Jason Netland, Stanley Perlman, Jason Netland
Abstract
Although coronaviruses were first identified nearly 60 years ago, they only received notoriety in 2003 when one of their members was identified as the aetiological agent of severe acute respiratory syndrome. Previously these viruses were known to be important agents of respiratory and enteric infections of domestic and companion animals and to cause approximately 15% of all cases of the common cold. This Review focuses on recent advances in our understanding of the mechanisms of coronavirus replication, interactions with the host immune response and disease pathogenesis. It also highlights the recent identification of numerous novel coronaviruses and the propensity of this virus family to cross species barriers.
Figures
References
- Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nature Med. 2004;10:S88–S97. doi: 10.1038/nm1143.
- Barcena M, et al. Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion. Proc. Natl Acad. Sci. USA. 2009;106:582–587. doi: 10.1073/pnas.0805270106.
- Neuman BW, et al. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J. Virol. 2006;80:7918–7928. doi: 10.1128/JVI.00645-06.
- Masters PS. The molecular biology of coronaviruses. Adv. Virus Res. 2006;66:193–292. doi: 10.1016/S0065-3527(06)66005-3.
- Lissenberg A, et al. Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. J. Virol. 2005;79:15054–15063. doi: 10.1128/JVI.79.24.15054-15063.2005.
- Hemmila E, et al. Ceacam1a−/− mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J. Virol. 2004;78:10156–10165. doi: 10.1128/JVI.78.18.10156-10165.2004.
- Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 2005;69:635–664. doi: 10.1128/MMBR.69.4.635-664.2005.
- Li W, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi: 10.1038/nature02145.
- Li W, et al. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology. 2007;367:367–374. doi: 10.1016/j.virol.2007.04.035.
- Hofmann H, et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl Acad. Sci. USA. 2005;102:7988–7993. doi: 10.1073/pnas.0409465102.
- Kuba K, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Med. 2005;11:875–879. doi: 10.1038/nm1267.
- Imai Y, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112–116. doi: 10.1038/nature03712.
- Ning Q, et al. Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4α. J. Biol. Chem. 2003;278:15541–15549. doi: 10.1074/jbc.M212806200.
- Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling. J. Biol. Chem. 2008;283:3272–3280. doi: 10.1074/jbc.M708033200.
- DeDiego ML, et al. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J. Virol. 2007;81:1701–1713. doi: 10.1128/JVI.01467-06.
- Kuo L, Masters PS. The small envelope protein E is not essential for murine coronavirus replication. J. Virol. 2003;77:4597–4608. doi: 10.1128/JVI.77.8.4597-4608.2003.
- Ortego J, Ceriani JE, Patino C, Plana J, Enjuanes L. Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway. Virology. 2007;368:296–308. doi: 10.1016/j.virol.2007.05.032.
- Madan V, Garcia Mde J, Sanz MA, Carrasco L. Viroporin activity of murine hepatitis virus E protein. FEBS Lett. 2005;579:3607–3612. doi: 10.1016/j.febslet.2005.05.046.
- McKinlay C, Gage P, Ewart G. SARS coronavirus E protein forms cation-selective ion channels. Virology. 2004;330:322–331. doi: 10.1016/j.virol.2004.09.033.
- Yount B, et al. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J. Virol. 2005;79:14909–14922. doi: 10.1128/JVI.79.23.14909-14922.2005.
- Ontiveros E, Kuo L, Masters PS, Perlman S. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology. 2001;290:230–238. doi: 10.1006/viro.2001.1167.
- de Haan CA, Masters PS, Shen X, Weiss S, Rottier PJ. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology. 2002;296:177–189. doi: 10.1006/viro.2002.1412.
- Li W, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310:676–679. doi: 10.1126/science.1118391.
- Fischer F, Peng D, Hingley ST, Weiss SR, Masters PS. The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J. Virol. 1997;71:996–1003.
- Huang C, Peters CJ, Makino S. Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J. Virol. 2007;81:5423–5426. doi: 10.1128/JVI.02307-06.
- Ito N, et al. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J. Virol. 2005;79:3182–3186. doi: 10.1128/JVI.79.5.3182-3186.2005.
- Schaecher SR, Mackenzie JM, Pekosz A. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J. Virol. 2007;81:718–731. doi: 10.1128/JVI.01691-06.
- Neuman BW, et al. Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J. Virol. 2008;82:5279–5294. doi: 10.1128/JVI.02631-07.
- Sawicki SG, Sawicki DL, Siddell SG. A contemporary view of coronavirus transcription. J. Virol. 2007;81:20–29. doi: 10.1128/JVI.01358-06.
- Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. doi: 10.1126/science.1085658.
- Zhai Y, et al. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nature Struct. Mol. Biol. 2005;12:980–986. doi: 10.1038/nsmb999.
- Chatterjee A, et al. Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold. J. Virol. 2009;83:1823–1836. doi: 10.1128/JVI.01781-08.
- Joseph JS, et al. Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs. J. Virol. 2006;80:7894–7901. doi: 10.1128/JVI.00467-06.
- Joseph JS, et al. Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch. J. Virol. 2007;81:6700–6708. doi: 10.1128/JVI.02817-06.
- Peti W, et al. Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7. J. Virol. 2005;79:12905–12913. doi: 10.1128/JVI.79.20.12905-12913.2005.
- Saikatendu KS, et al. Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1′'-phosphate dephosphorylation by a conserved domain of nsP3. Structure. 2005;13:1665–1675. doi: 10.1016/j.str.2005.07.022.
- Almeida MS, Johnson MA, Herrmann T, Geralt M, Wuthrich K. Novel β -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus. J. Virol. 2007;81:3151–3161. doi: 10.1128/JVI.01939-06.
- Serrano P, et al. Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus. J. Virol. 2007;81:12049–12060. doi: 10.1128/JVI.00969-07.
- Ricagno S, et al. Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family. Proc. Natl Acad. Sci. USA. 2006;103:11892–11897. doi: 10.1073/pnas.0601708103.
- Su D, et al. Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10. J. Virol. 2006;80:7902–7908. doi: 10.1128/JVI.00483-06.
- Snijder EJ, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 2003;331:991–1004. doi: 10.1016/S0022-2836(03)00865-9.
- Imbert I, et al. A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus. EMBO J. 2006;25:4933–4942. doi: 10.1038/sj.emboj.7601368.
- Ratia K, et al. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc. Natl Acad. Sci. USA. 2006;103:5717–5722. doi: 10.1073/pnas.0510851103.
- Deming DJ, Graham RL, Denison MR, Baric RS. Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication. J. Virol. 2007;81:10280–10291. doi: 10.1128/JVI.00017-07.
- Egloff MP, et al. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc. Natl Acad. Sci. USA. 2004;101:3792–3796. doi: 10.1073/pnas.0307877101.
- Donaldson EF, Sims AC, Graham RL, Denison MR, Baric RS. Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis. J. Virol. 2007;81:6356–6368. doi: 10.1128/JVI.02805-06.
- Eckerle LD, Lu X, Sperry SM, Choi L, Denison MR. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 2007;81:12135–12144. doi: 10.1128/JVI.01296-07.
- Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106).
- Ivanov KA, et al. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl Acad. Sci. USA. 2004;101:12694–12699. doi: 10.1073/pnas.0403127101.
- Decroly E, et al. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2′O)-methyltransferase activity. J. Virol. 2008;82:8071–8084. doi: 10.1128/JVI.00407-08.
- Snijder EJ, et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 2006;80:5927–5940. doi: 10.1128/JVI.02501-05.
- de Haan CA, Rottier PJ. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 2005;64:165–230. doi: 10.1016/S0065-3527(05)64006-7.
- Prentice E, Jerome WG, Yoshimori T, Mizushima N, Denison MR. Coronavirus replication complex formation utilizes components of cellular autophagy. J. Biol. Chem. 2004;279:10136–10141. doi: 10.1074/jbc.M306124200.
- Zhao Z, et al. Coronavirus replication does not require the autophagy gene ATG5. Autophagy. 2007;3:581–585. doi: 10.4161/auto.4782.
- Bechill J, Chen Z, Brewer JW, Baker SC. Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. J. Virol. 2008;82:4492–4501. doi: 10.1128/JVI.00017-08.
- Knoops K, et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008;6:e226. doi: 10.1371/journal.pbio.0060226.
- Snijder EJ, van Tol H, Roos N, Pedersen KW. Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex. J. Gen. Virol. 2001;82:985–994. doi: 10.1099/0022-1317-82-5-985.
- Clementz MA, Kanjanahaluethai A, O'Brien TE, Baker SC. Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles. Virology. 2008;375:118–129. doi: 10.1016/j.virol.2008.01.018.
- Kanjanahaluethai A, Chen Z, Jukneliene D, Baker SC. Membrane topology of murine coronavirus replicase nonstructural protein 3. Virology. 2007;361:391–401. doi: 10.1016/j.virol.2006.12.009.
- Oostra M, et al. Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J. Virol. 2008;82:12392–12405. doi: 10.1128/JVI.01219-08.
- Oostra M, et al. Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication. J. Virol. 2007;81:12323–12336. doi: 10.1128/JVI.01506-07.
- Garbino J, et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin. Infect. Dis. 2006;43:1009–1015. doi: 10.1086/507898.
- Gu J, et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005;202:415–424. doi: 10.1084/jem.20050828.
- Fouchier RA, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl Acad. Sci. USA. 2004;101:6212–6216. doi: 10.1073/pnas.0400762101.
- van der Hoek L, et al. Identification of a new human coronavirus. Nature Med. 2004;10:368–373. doi: 10.1038/nm1024.
- Woo PC, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 2005;79:884–895. doi: 10.1128/JVI.79.2.884-895.2005.
- Pyrc K, et al. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J. Mol. Biol. 2006;364:964–973. doi: 10.1016/j.jmb.2006.09.074.
- van der Hoek L, et al. Croup is associated with the novel coronavirus NL63. PLoS Med. 2005;2:e240. doi: 10.1371/journal.pmed.0020240.
- Donaldson EF, et al. Systematic assembly of a full-length infectious clone of human coronavirus NL63. J. Virol. 2008;82:11948–11957. doi: 10.1128/JVI.01804-08.
- Rottier PJ, Nakamura K, Schellen P, Volders H, Haijema BJ. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J. Virol. 2005;79:14122–14130. doi: 10.1128/JVI.79.22.14122-14130.2005.
- de Groot-Mijnes JD, van Dun JM, van der Most RG, de Groot RJ. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J. Virol. 2005;79:1036–1044. doi: 10.1128/JVI.79.2.1036-1044.2005.
- Vennema H, et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 1990;64:1407–1409.
- Guan Y, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–278. doi: 10.1126/science.1087139.
- Riley S, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003;300:1961–1966. doi: 10.1126/science.1086478.
- Chinese SMEC. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303:1666–1669. doi: 10.1126/science.1092002.
- Song HD, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl Acad. Sci. USA. 2005;102:2430–2435. doi: 10.1073/pnas.0409608102.
- Li W, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24:1634–1643. doi: 10.1038/sj.emboj.7600640.
- Sheahan T, Rockx B, Donaldson E, Corti D, Baric R. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus. J. Virol. 2008;82:8721–8732. doi: 10.1128/JVI.00818-08.
- Poon LL, et al. Identification of a novel coronavirus in bats. J. Virol. 2005;79:2001–2009. doi: 10.1128/JVI.79.4.2001-2009.2005.
- Lau SK, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl Acad. Sci. USA. 2005;102:14040–14045. doi: 10.1073/pnas.0506735102.
- Leung DT, et al. Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens. J. Virol. 2006;80:8920–8928. doi: 10.1128/JVI.00649-06.
- Becker MM, et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl Acad. Sci. USA. 2008;105:19944–19949. doi: 10.1073/pnas.0808116105.
- Ren W, et al. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J. Virol. 2008;82:1899–1907. doi: 10.1128/JVI.01085-07.
- Vijgen L, et al. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J. Virol. 2005;79:1595–1604. doi: 10.1128/JVI.79.3.1595-1604.2005.
- Alekseev KP, et al. Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences. J. Virol. 2008;82:12422–12431. doi: 10.1128/JVI.01586-08.
- Jin L, et al. Analysis of the genome sequence of an alpaca coronavirus. Virology. 2007;365:198–203. doi: 10.1016/j.virol.2007.03.035.
- Lorusso A, et al. Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J. Virol. 2008;82:10312–10317. doi: 10.1128/JVI.01031-08.
- Woo PC, et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J. Virol. 2007;81:1574–1585. doi: 10.1128/JVI.02182-06.
- Dominguez SR, O'Shea TJ, Oko LM, Holmes KV. Detection of group 1 coronaviruses in bats in North America. Emerg. Infect. Dis. 2007;13:1295–1300. doi: 10.3201/eid1309.070491.
- Gloza-Rausch F, et al. Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg. Infect. Dis. 2008;14:626–631. doi: 10.3201/eid1404.071439.
- Tong S, et al. Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg. Infect. Dis. 2009;15:482–485. doi: 10.3201/eid1503.081013.
- Woo PC, et al. Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus. J. Virol. 2009;83:908–917. doi: 10.1128/JVI.01977-08.
- Dong BQ, et al. Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China. J. Virol. 2007;81:6920–6926. doi: 10.1128/JVI.00299-07.
- Mihindukulasuriya KA, Wu G, St Leger J, Nordhausen RW, Wang D. Identification of a novel coronavirus from a beluga whale by using a panviral microarray. J. Virol. 2008;82:5084–5088. doi: 10.1128/JVI.02722-07.
- Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nature Rev. Immunol. 2005;5:917–927. doi: 10.1038/nri1732.
- Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: host–virus stand-off. Nature Rev. Microbiol. 2006;4:121–132. doi: 10.1038/nrmicro1343.
- Savarin C, Bergmann CC, Hinton DR, Ransohoff RM, Stohlman SA. Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis. J. Virol. 2008;82:12432–12440. doi: 10.1128/JVI.01267-08.
- Kim TS, Perlman S. Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus. Am. J. Pathol. 2005;166:801–809. doi: 10.1016/S0002-9440(10)62301-2.
- Kim TS, Perlman S. Viral expression of CCL2 is sufficient to induce demyelination in RAG1−/− mice infected with a neurotropic coronavirus. J. Virol. 2005;79:7113–7120. doi: 10.1128/JVI.79.11.7113-7120.2005.
- Williamson JS, Stohlman SA. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol. 1990;64:4589–4592.
- Anghelina D, Pewe L, Perlman S. Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am. J. Pathol. 2006;169:209–222. doi: 10.2353/ajpath.2006.051308.
- Deming D, et al. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med. 2006;3:e525. doi: 10.1371/journal.pmed.0030525.
- Roberts A, et al. A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 2007;3:e5. doi: 10.1371/journal.ppat.0030005.
- Roberts A, et al. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J. Virol. 2005;79:5833–5838. doi: 10.1128/JVI.79.9.5833-5838.2005.
- Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology. 2007;361:18–26. doi: 10.1016/j.virol.2007.01.020.
- Zhou H, Perlman S. Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J. Virol. 2007;81:568–574. doi: 10.1128/JVI.01512-06.
- Spiegel M, et al. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 2005;79:2079–2086. doi: 10.1128/JVI.79.4.2079-2086.2005.
- He R, et al. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 2003;311:870–876. doi: 10.1016/j.bbrc.2003.10.075.
- Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P. SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists. J. Virol. 2006;81:548–557. doi: 10.1128/JVI.01782-06.
- Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J. Virol. 2007;81:2554–2563. doi: 10.1128/JVI.01634-06.
- Narayanan K, et al. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 2008;82:4471–4479. doi: 10.1128/JVI.02472-07.
- Wathelet MG, Orr M, Frieman MB, Baric RS. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 2007;81:11620–11633. doi: 10.1128/JVI.00702-07.
- Zust R, et al. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog. 2007;3:e109. doi: 10.1371/journal.ppat.0030109.
- Frieman M, et al. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 2007;81:9812–9824. doi: 10.1128/JVI.01012-07.
- Hussain S, Perlman S, Gallagher TM. Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism. J. Virol. 2008;82:7212–7222. doi: 10.1128/JVI.02406-07.
- Zhao J, et al. Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication. J. Virol. 2008;83:2368–2373. doi: 10.1128/JVI.02371-08.
- Kamitani W, et al. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl Acad. Sci. USA. 2006;103:12885–12890. doi: 10.1073/pnas.0603144103.
- Devaraj SG, et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007;282:32208–32221. doi: 10.1074/jbc.M704870200.
- Cameron MJ, et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 2007;81:8692–8706. doi: 10.1128/JVI.00527-07.
- Rempel JD, Murray SJ, Meisner J, Buchmeier MJ. Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology. 2004;318:381–392. doi: 10.1016/j.virol.2003.09.023.
- Ireland DD, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 2008;82:300–310. doi: 10.1128/JVI.01794-07.
- Cervantes-Barragan L, et al. Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon. Blood. 2006;109:1131–1137. doi: 10.1182/blood-2006-05-023770.
- Roth-Cross JK, Bender SJ, Weiss SR. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 2008;82:9829–9838. doi: 10.1128/JVI.01199-08.
- Cervantes-Barragan L, et al. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 2009;182:1099–1106. doi: 10.4049/jimmunol.182.2.1099.
- He L, et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006;210:288–297. doi: 10.1002/path.2067.
- Li CK, et al. T cell responses to whole SARS coronavirus in humans. J. Immunol. 2008;181:5490–5500. doi: 10.4049/jimmunol.181.8.5490.
- Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am. J. Pathol. 2007;170:1136–1147. doi: 10.2353/ajpath.2007.061088.
- Chen J, Subbarao K. The immunobiology of SARS. Annu. Rev. Immunol. 2007;25:443–472. doi: 10.1146/annurev.immunol.25.022106.141706.
- Subbarao K, Roberts A. Is there an ideal animal model for SARS? Trends Microbiol. 2006;14:299–303. doi: 10.1016/j.tim.2006.05.007.
- McCray PB, Jr, et al. Lethal infection in K18-hACE2 mice infected with SARS-CoV. J. Virol. 2006;81:813–821. doi: 10.1128/JVI.02012-06.
- Tseng CT, et al. SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor. J. Virol. 2006;81:1162–1173. doi: 10.1128/JVI.01702-06.
- Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82:7264–7275. doi: 10.1128/JVI.00737-08.
- Lee DT, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin. Infect. Dis. 2004;39:1247–1249. doi: 10.1086/424016.
- Xu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 2005;41:1089–1096. doi: 10.1086/444461.
- Nagata N, et al. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am. J. Pathol. 2008;172:1625–1637. doi: 10.2353/ajpath.2008.071060.
- Nagata N, et al. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J. Virol. 2007;81:1848–1857. doi: 10.1128/JVI.01967-06.
- de Lang A, et al. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog. 2007;3:e112. doi: 10.1371/journal.ppat.0030112.
- Baas T, et al. Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. J. Virol. 2008;82:9465–9476. doi: 10.1128/JVI.00489-08.
- Morahan G, Balmer L, Monley D. Establishment of “The Gene Mine”: a resource for rapid identification of complex trait genes. Mamm. Genome. 2008;19:390–393. doi: 10.1007/s00335-008-9134-9.
- Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. doi: 10.1371/journal.pmed.0030343.
- Gosert R, Kanjanahaluethai A, Egger D, Bienz K, Baker SC. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 2002;76:3697–3708. doi: 10.1128/JVI.76.8.3697-3708.2002.
- Sims AC, Ostermann J, Denison MR. Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes. J. Virol. 2000;74:5647–5654. doi: 10.1128/JVI.74.12.5647-5654.2000.
Source: PubMed